Vital Sign Monitors Global Market Report 2025

The vital sign monitors market size has grown strongly in recent years. It will grow from $1.34 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. This growth during the historical period can be attributed to factors such as a rise in chronic disease prevalence, an aging global population, increased awareness of health monitoring, greater adoption of wearable and wireless technologies, and the growing need for home-based health monitoring.

The vital sign monitors market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The projected growth in the coming years will be driven by the expansion of telehealth and remote monitoring services, supportive government initiatives aimed at promoting health surveillance, an increase in hospital and clinic development, heightened emphasis on early diagnosis and preventative care, and a rising rate of cardiovascular disorders. Key trends anticipated in this period include continued technological progress in monitoring systems, enhancements in sensor capabilities, integration of AI and machine learning for predictive insights, and growing demand for compact and portable monitoring solutions.

The growing demand for telemedicine is expected to drive the expansion of the vital sign monitor market. Telemedicine involves the use of technology to provide healthcare services and consultations remotely, eliminating the need for in-person visits. This approach offers convenient access to medical care, enabling patients to consult with doctors from the comfort of their homes, thereby saving time and reducing the need for travel. As telemedicine expands, the need for vital sign monitors increases, as these devices allow for the remote tracking of patients’ health metrics and ensure accurate, real-time monitoring during virtual consultations. For example, in February 2023, a survey conducted by Rock Health - a U.S.-based company focused on digital health and healthcare innovation - with 8,014 respondents between July and August 2022 found that 80% of participants had used telemedicine at least once in 2022, an 8% increase from 72% in 2021. Therefore, the rising demand for telemedicine is expected to support the growth of the vital sign monitor market.

Companies operating in the vital sign monitor market are increasingly developing advanced devices with integrated early warning scoring systems to reduce the risk of human error. These systems continuously evaluate patient vital signs to identify early indicators of clinical deterioration and support timely medical responses. For instance, in July 2024, Huntleigh, a U.S.-based medical equipment manufacturer, introduced the SC500 Series vital signs monitor. This device supports both spot checks and medium- to long-term observations, bridging the gap between entry-level and multi-parameter monitors. It includes integrated early warning scoring tools and three-level alarms, making it especially suitable for long COVID-19 monitoring. With an 8-inch color display and operation via battery or mains power, the SC500 offers comprehensive monitoring for adults, children, and newborns. It measures non-invasive blood pressure, pulse rate, pulse oximetry, 3-lead ECG, and includes an optional wireless tympanic temperature sensor. The device also enhances workflow efficiency through standard connectivity and compatibility with Smartsigns Central View monitoring software for centralized data management.

In August 2022, Medtronic Plc, an Ireland-based medical device company, formed a partnership with BioIntelliSense to distribute multi-parameter wearable devices for continuous remote patient monitoring in the United States. Through this agreement, Medtronic gained exclusive rights to distribute the BioButton wearable across U.S. hospitals and for up to 30 days following a patient’s discharge. BioIntelliSense is a U.S.-based manufacturer specializing in vital sign monitoring devices.

Major players in the vital sign monitors market are Medtronic Plc, Koninklijke Philips NV, GE Healthcare Technologies Inc., Baxter International Inc., Omron Healthcare, Mindray Ltd., Masimo Corp., Nihon Kohden Corp., Lepu Medical Technology Co. Ltd., Contec Medical Systems Co. Ltd., iRhythm Technologies Inc., A&D Company Ltd., Spacelabs Healthcare Inc., Schiller AG, Edan Instruments Inc., Shenzhen Comen Medical Instruments Co. Ltd., Nonin Medical Inc., Recorders & Medicare Systems P Ltd., BPL Medical Technologies, SunTech Medical Inc., Rossmax International Ltd., Allengers Medical Systems Ltd., Huntleigh Healthcare LLC, BioBeat Technologies, Ababil Healthcare.

North America was the largest region in the vital sign monitors market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in vital sign monitors report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vital sign monitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Vital signs monitors are medical instruments designed to either continuously or periodically track and display key physiological metrics that reflect the body’s essential functions. These devices play a critical role in evaluating a patient’s overall health status, identifying early signs of medical conditions, and monitoring progress during recovery.

These monitors consist of three main components: hardware, software, and services. The hardware includes physical parts such as sensors, display units, and processing systems responsible for measuring and presenting vital data like heart rate, blood pressure, and oxygen levels. These devices support both wired and wireless operations and are utilized across various settings, including hospitals, ambulatory surgical centers, home healthcare environments, and more. End-users span across healthcare professionals, individual patients, and research institutions.

The vital sign monitors market research report is one of a series of new reports that provides vital sign monitors market statistics, including vital sign monitors industry global market size, regional shares, competitors with a vital sign monitors market share, detailed vital sign monitors market segments, market trends and opportunities, and any further data you may need to thrive in the vital sign monitors industry. This vital sign monitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vital sign monitors market consists of revenues earned by entities by providing services such as device installation, remote patient monitoring services, cloud data management, and data reporting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The vital sign monitors market also includes sales of neonatal vital sign monitors, capnography monitors, continuous glucose monitors, and telehealth vital sign monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.